Identifiers
4-Fluoro-5-Methoxy-N,N-dimethyltryptamine
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
C13H17FN2O
236.290 g·mol−1
3D model (JSmol)
CN(C)CCC1=CNC2=C1C(=C(C=C2)OC)F
InChI=1S/C13H17FN2O/c1-16(2)7-6-9-8-15-10-4-5-11(17-3)13(14)12(9)10/h4-5,8,15H,6-7H2,1-3H3
Key:CTEKFOKTEGQYLO-UHFFFAOYSA-N
4-Fluoro-5-Methoxy-N,N-dimethyltryptamine (4-F-5-MeO-DMT) was first described by David E. Nichols team in 2000. It is a potent 5-HT1A agonist. Substitution with the 4-fluorine markedly increased 5-HT1A selectivity over 5-HT2A/2C receptors with potency greater than that of the 5-HT1A agonist 8-OH-DPAT.[1]
The analog compound with the N,N-dialkyl substituents constrained into a pyrrolidine ring, is a slightly stronger agonist for the 5-HT1A receptor and retains the selectivity over the 5-HT2A/2C receptors.[2]
Psychedelics
(5-HT2A
agonists)
25x-NB3OMe
25x-NB4OMe
25x-NBF
25x-NBMD
25x-NBOH
25x-NBOMe
Atypical structures
25x-NMx
3C-x
4C-x
HOT-x
Mescaline (subst.)
Others
x-DALT
x-DET
x-DiPT
x-DMT
x-DPT
Ibogaine-related
x-MET
x-MiPT
Others
Others
PCP-related
Others
Diarylethylamines
Others
Others
GABAA
enhancers
Others